XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 109,426 $ 123,554
Marketable securities 503,343 516,598
Prepaid expenses and other current assets 11,629 11,143
Total current assets 624,398 651,295
Restricted cash 281 280
Marketable securities, non-current 55,255 70,117
Other investments 34,924 44,924
Property and equipment, net 118,600 123,023
Operating lease right-of-use assets 42,390 43,242
Other non-current assets 4,602 4,680
Total assets 880,450 937,561
Current liabilities:    
Accounts payable 5,733 3,917
Accrued liabilities and other current liabilities 22,416 28,755
Success payment liabilities 2,648 4,356
Total current liabilities 30,797 37,028
Operating lease liabilities, non-current 61,826 63,168
Other non-current liabilities 4,001 4,113
Total liabilities 96,624 104,309
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 10,000 shares authorized at March 31, 2023 and December 31, 2022; no shares issued and outstanding at March 31, 2023 and December 31, 2022 0 0
Common stock, $0.0001 par value; 500,000 shares authorized at March 31, 2023 and December 31, 2022; 249,609 and 249,567 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively 25 25
Additional paid-in capital 1,622,119 1,608,306
Accumulated other comprehensive loss (3,879) (7,599)
Accumulated deficit (834,439) (767,480)
Total stockholders’ equity 783,826 833,252
Total liabilities and stockholders’ equity $ 880,450 $ 937,561